Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Bain Capital targets $7bn for new Asia fund and raises $2.1bn for special situations strategy
Bain Capital targets $7bn for new Asia fund and raises $2.1bn for special situations strategy Bain Capital is seeking to raise at least $7bn for its sixth Asia-focused private equity fund, marking one of the largest regional fundraising efforts in recent months. The...
CVC appoints John Kelleher as Managing Partner to lead global operations and drive portfolio value
CVC appoints John Kelleher as Managing Partner to lead global operations and drive portfolio value CVC has named John Kelleher as a Managing Partner, effective early Q3 2025, as part of a strategic leadership transition aimed at strengthening operational excellence...
Pantheon’s $5.2bn fund and Coller’s $1.6bn deal signal turning point for private credit secondaries amid market chaos
Pantheon’s $5.2bn fund and Coller’s $1.6bn deal signal turning point for private credit secondaries amid market chaos Pantheon and Coller Capital are leading a rising wave of private credit secondary activity, as market volatility prompts institutional investors to...